Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” The post Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue appeared first on Medical Device Network.

The post Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenue appeared first on Medical Device Network.